Evotec SE Correlations
EVOTF Stock | USD 6.77 0.00 0.00% |
The current 90-days correlation between Evotec SE and Pacira BioSciences, is -0.06 (i.e., Good diversification). The correlation of Evotec SE is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Evotec SE Correlation With Market
Average diversification
The correlation between Evotec SE and DJI is 0.1 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding Evotec SE and DJI in the same portfolio, assuming nothing else is changed.
Evotec |
The ability to find closely correlated positions to Evotec SE could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Evotec SE when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Evotec SE - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Evotec SE to buy it.
Moving together with Evotec Pink Sheet
0.77 | MKKGY | Merck KGaA ADR | PairCorr |
0.76 | MKGAF | MERCK Kommanditgesells | PairCorr |
0.66 | HLN | Haleon plc | PairCorr |
0.7 | TAK | Takeda Pharmaceutical | PairCorr |
0.63 | HLNCF | Haleon plc | PairCorr |
0.81 | EPGG | Empire Global Gaming | PairCorr |
0.63 | JNJ | Johnson Johnson Fiscal Year End 28th of January 2025 | PairCorr |
0.68 | KO | Coca Cola Sell-off Trend | PairCorr |
0.63 | BA | Boeing Fiscal Year End 29th of January 2025 | PairCorr |
0.8 | MRK | Merck Company Fiscal Year End 6th of February 2025 | PairCorr |
Moving against Evotec Pink Sheet
0.81 | VRT | Vertiv Holdings | PairCorr |
0.78 | PYPL | PayPal Holdings Aggressive Push | PairCorr |
0.79 | CAT | Caterpillar Fiscal Year End 3rd of February 2025 | PairCorr |
0.74 | CVX | Chevron Corp Sell-off Trend | PairCorr |
0.69 | T | ATT Inc Aggressive Push | PairCorr |
0.67 | INTC | Intel Fiscal Year End 23rd of January 2025 | PairCorr |
0.65 | WMT | Walmart Aggressive Push | PairCorr |
0.63 | BAC | Bank of America Aggressive Push | PairCorr |
0.62 | TRV | The Travelers Companies Fiscal Year End 17th of January 2025 | PairCorr |
0.56 | JPM | JPMorgan Chase Sell-off Trend | PairCorr |
0.54 | NDAQ | Nasdaq Inc | PairCorr |
0.54 | DIS | Walt Disney Aggressive Push | PairCorr |
0.46 | IBM | International Business Fiscal Year End 22nd of January 2025 | PairCorr |
0.42 | MCD | McDonalds Fiscal Year End 3rd of February 2025 | PairCorr |
0.37 | GE | GE Aerospace Fiscal Year End 28th of January 2025 | PairCorr |
Related Correlations Analysis
Click cells to compare fundamentals | Check Volatility | Backtest Portfolio |
Correlation Matchups
Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.High positive correlations
| High negative correlations
|
Risk-Adjusted Indicators
There is a big difference between Evotec Pink Sheet performing well and Evotec SE Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze Evotec SE's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.Mean Deviation | Jensen Alpha | Sortino Ratio | Treynor Ratio | Semi Deviation | Expected Shortfall | Potential Upside | Value @Risk | Maximum Drawdown | ||
---|---|---|---|---|---|---|---|---|---|---|
PCRX | 1.92 | 0.11 | 0.05 | 0.22 | 2.09 | 3.96 | 10.38 | |||
COLL | 1.88 | (0.41) | 0.00 | (0.22) | 0.00 | 3.23 | 12.29 | |||
PBH | 0.94 | 0.12 | 0.07 | 0.29 | 1.04 | 1.90 | 4.90 | |||
PAHC | 1.82 | 0.02 | 0.04 | 0.13 | 1.72 | 3.86 | 9.05 | |||
HCM | 2.39 | (0.01) | (0.02) | 0.10 | 2.65 | 5.32 | 12.71 | |||
NBIX | 1.52 | (0.40) | 0.00 | (0.16) | 0.00 | 3.10 | 19.06 | |||
DCPH | 1.66 | (0.22) | 0.00 | (1.16) | 0.00 | 3.27 | 9.66 | |||
IRWD | 3.37 | (0.76) | 0.00 | (0.18) | 0.00 | 6.62 | 20.41 | |||
ALKS | 1.76 | (0.16) | (0.03) | 0.03 | 2.06 | 4.14 | 9.74 | |||
AVDL | 2.43 | (0.62) | 0.00 | (0.53) | 0.00 | 4.18 | 39.15 |
Be your own money manager
Our tools can tell you how much better you can do entering a position in Evotec SE without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Fundamental Analysis Now
Fundamental AnalysisView fundamental data based on most recent published financial statements |
All Next | Launch Module |
Evotec SE Corporate Management
Matthias Evers | Chief Board | Profile | |
Volker Braun | VP ESG | Profile | |
Cord Dohrmann | Chief Scientific Officer and Member of Management Board | Profile | |
Monika Conradt | Global HR | Profile | |
Christian Dargel | EVP Compliance | Profile |